{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:29:29Z","timestamp":1792578569244,"version":"4.5.0"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Research and Development Fund"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871436"],"award-info":[{"award-number":["81871436"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Informatization Special Project of Chinese Academy of Sciences","award":["XXH13506\u2013 306"],"award-info":[{"award-number":["XXH13506\u2013 306"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Spinal cord involvement is a hallmark feature of multiple sclerosis, neuromyelitis optica with AQP4 antibodies and MOG-antibody disease. In this cross-sectional study we use quantitative spinal cord MRI to better understand these conditions, differentiate them and associate with relevant clinical outcomes. Eighty participants (20 in each disease group and 20 matched healthy volunteers) underwent spinal cord MRI (cervical cord: 3D T1, 3D T2, diffusion tensor imaging and magnetization transfer ratio; thoracic cord: 3D T2), together with disability, pain and fatigue scoring. All participants had documented spinal cord involvement and were at least 6 months post an acute event. MRI scans were analysed using publicly available software. Those with AQP4-antibody disease showed a significant reduction in cervical cord cross-sectional area (P\u2009=\u20090.038), thoracic cord cross-sectional area (P\u2009=\u20090.043), cervical cord grey matter (P\u2009=\u20090.011), magnetization transfer ratio (P\u2009\u2264\u20090.001), fractional anisotropy (P\u2009=\u20090.004) and increased mean diffusivity (P\u2009=\u20090.008). Those with multiple sclerosis showed significantly increased mean diffusivity (P\u2009=\u20090.001) and reduced fractional anisotropy (P\u2009=\u20090.013), grey matter volume (P\u2009=\u20090.002) and magnetization transfer ratio (P\u2009=\u20090.011). In AQP4-antibody disease the damage was localized to areas of the cord involved in the acute attack. In multiple sclerosis this relationship with lesions was absent. MOG-antibody disease did not show significant differences to healthy volunteers in any modality. However, when considering only areas involved at the time of the acute attack, a reduction in grey matter volume was found (P\u2009=\u20090.023). This suggests a predominant central grey matter component to MOG-antibody myelitis, which we hypothesize could be partially responsible for the significant residual sphincter dysfunction. Those with relapsing MOG-antibody disease showed a reduction in cord cross-sectional area compared to those with monophasic disease, even when relapses occurred elsewhere (P\u2009=\u20090.012). This suggests that relapsing MOG-antibody disease is a more severe phenotype. We then applied a principal component analysis, followed by an orthogonal partial least squares analysis. MOG-antibody disease was discriminated from both AQP4-antibody disease and multiple sclerosis with moderate predictive values. Finally, we assessed the clinical relevance of these metrics using a multiple regression model. Cervical cord cross-sectional area associated with disability scores (B = \u22120.07, P\u2009=\u20090.0440, R2 = 0.20) and cervical cord spinothalamic tract fractional anisotropy associated with pain scores (B = \u221219.57, P\u2009=\u20090.016, R2 = 0.55). No spinal cord metric captured fatigue. This work contributes to our understanding of myelitis in these conditions and highlights the clinical relevance of quantitative spinal cord MRI.<\/jats:p>","DOI":"10.1093\/brain\/awaa347","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T15:16:29Z","timestamp":1601306189000},"page":"198-212","source":"Crossref","is-referenced-by-count":70,"title":["Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis"],"prefix":"10.1093","volume":"144","author":[{"given":"Romina","family":"Mariano","sequence":"first","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Messina","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Roca-Fernandez","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria I","family":"Leite","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhuo","family":"Kong","sequence":"additional","affiliation":[{"name":"CAS Key Laboratory of Behavioral Science, Institute of Psychology, Chinese Academy of Sciences, Beijing 100101, China"},{"name":"Department of Psychology, University of Chinese Academy of Sciences, Beijing 100049, China"},{"name":"Wellcome Centre for Integrative Neuroimaging, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A","family":"Palace","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,18]]},"reference":[{"key":"2021021220580857800_awaa347-B1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.msard.2013.09.007","article-title":"Sample sizes for lesion magnetisation transfer ratio outcomes in remyelination trials for multiple sclerosis","volume":"3","author":"Altmann","year":"2014","journal-title":"Mult Scler Relat Disord"},{"key":"2021021220580857800_awaa347-B2","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S1053-8119(03)00336-7","article-title":"How to correct susceptibility distortions in spin-echo echo-planar images: application to diffusion tensor imaging","volume":"20","author":"Andersson","year":"2003","journal-title":"Neuroimage"},{"key":"2021021220580857800_awaa347-B3","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neuroimage.2015.10.019","article-title":"An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging","volume":"125","author":"Andersson","year":"2016","journal-title":"Neuroimage"},{"key":"2021021220580857800_awaa347-B4","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.25072","article-title":"Imaging spinal cord atrophy in progressive myelopathies: HTLV-I-associated neurological disease (HAM\/TSP) and multiple sclerosis","volume":"82","author":"Azodi","year":"2017","journal-title":"Ann Neurol"},{"key":"2021021220580857800_awaa347-B5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1212\/01.wnl.0000223637.65208.7c","article-title":"Grading cervical cord damage in neuromyelitis optica and MS by diffusion tensor MRI","volume":"67","author":"Benedetti","year":"2006","journal-title":"Neurology"},{"key":"2021021220580857800_awaa347-B6","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/sleep\/33.8.1061","article-title":"Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment","volume":"33","author":"Braley","year":"2010","journal-title":"Sleep"},{"key":"2021021220580857800_awaa347-B7","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1007\/s00415-006-0503-6","article-title":"Cortical atrophy is relevant in multiple sclerosis at clinical onset","volume":"254","author":"Calabrese","year":"2007","journal-title":"J Neurol"},{"key":"2021021220580857800_awaa347-B8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/jon.12553","article-title":"Spinal cord atrophy in multiple sclerosis: a systematic review and meta-analysis","volume":"28","author":"Casserly","year":"2018","journal-title":"J Neuroimaging"},{"key":"2021021220580857800_awaa347-B9","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1177\/1352458517709954","article-title":"Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis","volume":"24","author":"Cawley","year":"2018","journal-title":"Mult Scler J"},{"key":"2021021220580857800_awaa347-B10","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1177\/1352458518815596","article-title":"Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity","volume":"25","author":"Chien","year":"2019","journal-title":"Mult Scler J"},{"key":"2021021220580857800_awaa347-B11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1474-4422(18)30460-5","article-title":"Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders","volume":"18","author":"Ciccarelli","year":"2019","journal-title":"Lancet Neurol"},{"key":"2021021220580857800_awaa347-B12","doi-asserted-by":"crossref","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology"},{"key":"2021021220580857800_awaa347-B32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuroimage.2016.10.009","article-title":"SCT: spinal Cord Toolbox, an open-source software for processing spinal cord MRI data","volume":"145","author":"De Leener","year":"2017","journal-title":"Neuroimage"},{"key":"2021021220580857800_awaa347-B13","first-page":"1","article-title":"Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody","volume":"55905","author":"Dubey","year":"2018","journal-title":"JAMA Neurol"},{"key":"2021021220580857800_awaa347-B14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jamaneurol.2018.4053","article-title":"Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody","volume":"76","author":"Dubey","year":"2019","journal-title":"JAMA Neurol"},{"key":"2021021220580857800_awaa347-B15","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/brain\/awy352","article-title":"Spatial distribution of multiple sclerosis lesions in the cervical spinal cord","volume":"142","author":"Eden","year":"2019","journal-title":"Brain"},{"key":"2021021220580857800_awaa347-B16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"GPower 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"2021021220580857800_awaa347-B17","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/brain\/awz144","article-title":"Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines","volume":"142","author":"Filippi","year":"2019","journal-title":"Brain"},{"key":"2021021220580857800_awaa347-B18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamaneurol.2014.2137","article-title":"Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders","volume":"72","author":"Flanagan","year":"2015","journal-title":"JAMA Neurol"},{"key":"2021021220580857800_awaa347-B19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1212\/CPJ.0000000000000104","article-title":"Asymptomatic myelitis in neuromyelitis optica and autoimmune aquaporin-4 channelopathy","volume":"5","author":"Flanagan","year":"2015","journal-title":"Neurol Clin Pract"},{"key":"2021021220580857800_awaa347-B20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrn2401","article-title":"The neural control of micturition","volume":"9","author":"Fowler","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"2021021220580857800_awaa347-B21","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1474-4422(08)70191-1","article-title":"Grey matter pathology in multiple sclerosis","volume":"7","author":"Geurts","year":"2008","journal-title":"Lancet Neurol"},{"key":"2021021220580857800_awaa347-B151","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.neuroimage.2018.09.081","article-title":"Automatic segmentation of the spinal cord and intramedullary multiple sclerosis lesions with convolutional neural networks","volume":"184","author":"Gros","year":"2019","journal-title":"Neuroimage"},{"key":"2021021220580857800_awaa347-B22","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0140-6736(17)30437-3","article-title":"Diagnostic algorithm for relapsing demyelinating syndromes of the CNS in children including myelin oligodendrocyte glycoprotein","volume":"389","author":"Hacohen","year":"2017","journal-title":"Lancet"},{"key":"2021021220580857800_awaa347-B23","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/1352458518758911","article-title":"Multiple sclerosis\u2013related fatigue: altered resting-state functional connectivity of the ventral striatum and dorsolateral prefrontal cortex","volume":"25","author":"Jaeger","year":"2019","journal-title":"Mult Scler J"},{"key":"2021021220580857800_awaa347-B24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients","volume":"9","author":"Jarius","year":"2012","journal-title":"J Neuroinflammation"},{"key":"2021021220580857800_awaa347-B25","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","article-title":"FSL","volume":"62","author":"Jenkinson","year":"2012","journal-title":"Neuroimage"},{"key":"2021021220580857800_awaa347-B26","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/brain\/aww350","article-title":"Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"key":"2021021220580857800_awaa347-B27","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"key":"2021021220580857800_awaa347-B28","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/brain\/aws109","article-title":"Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan","volume":"135","author":"Kitley","year":"2012","journal-title":"Brain"},{"key":"2021021220580857800_awaa347-B29","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies a comparative study","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol"},{"key":"2021021220580857800_awaa347-B30","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1177\/1352458512436593","article-title":"Increased radial diffusivity in spinal cord lesions in neuromyelitis optica compared with multiple sclerosis","volume":"18","author":"Klawiter","year":"2012","journal-title":"Mult Scler J"},{"key":"2021021220580857800_awaa347-B31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.24554","article-title":"Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses","volume":"79","author":"Kleiter","year":"2016","journal-title":"Ann Neurol"},{"key":"2021021220580857800_awaa347-B33","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1212\/WNL.0000000000001441","article-title":"Differential patterns of spinal cord and brain atrophy in NMO and MS","volume":"84","author":"Liu","year":"2015","journal-title":"Neurology"},{"key":"2021021220580857800_awaa347-B34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/bpa.12099","article-title":"The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica","volume":"24","author":"Lucchinetti","year":"2014","journal-title":"Brain Pathol"},{"key":"2021021220580857800_awaa347-B35","doi-asserted-by":"crossref","first-page":"e1912732","DOI":"10.1001\/jamanetworkopen.2019.12732","article-title":"Comparison of clinical outcomes of transverse myelitis among adults with myelin oligodendrocyte glycoprotein antibody vs aquaporin-4 antibody disease","volume":"2","author":"Mariano","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2021021220580857800_awaa347-B36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0137715","article-title":"Imaging surrogates of disease activity in neuromyelitis optica allow distinction from multiple sclerosis","volume":"10","author":"Matthews","year":"2015","journal-title":"PLoS One"},{"key":"2021021220580857800_awaa347-B37","author":"McCarthy","year":"2019"},{"key":"2021021220580857800_awaa347-B38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/brain\/121.1.3","article-title":"The role of magnetic resonance techniques in understanding and managing multiple sclerosis","volume":"121","author":"Miller","year":"1998","journal-title":"Brain"},{"key":"2021021220580857800_awaa347-B39","doi-asserted-by":"crossref","first-page":"1756286419840593","DOI":"10.1177\/1756286419840593","article-title":"Advances in spinal cord imaging in multiple sclerosis","volume":"12","author":"Moccia","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"key":"2021021220580857800_awaa347-B40","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/ana.22521","article-title":"Multiple sclerosis normal-appearing white matter: pathology-imaging correlations","volume":"70","author":"Moll","year":"2011","journal-title":"Ann Neurol"},{"key":"2021021220580857800_awaa347-B41","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1212\/WNL.0b013e318296e8f1","article-title":"Spinal cord tract diffusion tensor imaging reveals disability substrate in demyelinating disease","volume":"80","author":"Naismith","year":"2013","journal-title":"Neurology"},{"key":"2021021220580857800_awaa347-B42","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000322","article-title":"MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy","volume":"4","author":"Ogawa","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2021021220580857800_awaa347-B43","first-page":"26","article-title":"Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis","volume":"13","author":"Olsson","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"2021021220580857800_awaa347-B44","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/1352458515572406","article-title":"Demographic and clinical features of neuromyelitis optica: a review","volume":"21","author":"Pandit","year":"2015","journal-title":"Mult Scler J"},{"key":"2021021220580857800_awaa347-B45","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1016\/j.ejrad.2011.11.026","article-title":"The cervical spinal cord in neuromyelitis optica patients: a comparative study with multiple sclerosis using diffusion tensor imaging","volume":"81","author":"Pess\u00f4a","year":"2012","journal-title":"Eur J Radiol"},{"key":"2021021220580857800_awaa347-B46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/brainsci8090173","article-title":"Ten key insights into the use of spinal cord fmri","volume":"8","author":"Powers","year":"2018","journal-title":"Brain Sci"},{"key":"2021021220580857800_awaa347-B47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1212\/WNL.0000000000005873","article-title":"Spinal cord atrophy rates: ready for prime time in multiple sclerosis clinical trials?","volume":"91","author":"Prados","year":"2018","journal-title":"Neurology"},{"key":"2021021220580857800_awaa347-B48","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1177\/1352458515569098","article-title":"Sample-size calculations for short-term proof-of-concept studies of tissue protection and repair in multiple sclerosis lesions via conventional clinical imaging","volume":"21","author":"Reich","year":"2015","journal-title":"Mult Scler J"},{"key":"2021021220580857800_awaa347-B49","first-page":"1381","article-title":"Seroprevalence and clinical phenotype of MOG-IgG-associated disorders in Sri Lanka","volume":"90","author":"Senanayake","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2021021220580857800_awaa347-B50","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1016\/j.neuroimage.2004.07.051","article-title":"Advances in functional and structural MR image analysis and implementation as FSL","volume":"23","author":"Smith","year":"2004","journal-title":"Neuroimage"},{"key":"2021021220580857800_awaa347-B51","doi-asserted-by":"crossref","first-page":"101426","DOI":"10.1016\/j.msard.2019.101426","article-title":"Correlation between EDSS scores and cervical spinal cord atrophy at 3T MRI in multiple sclerosis: a systematic review and meta-analysis","volume":"37","author":"Song","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"2021021220580857800_awaa347-B52","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.neuroimage.2013.04.124","article-title":"The current state-of-the-art of spinal cord imaging: methods","volume":"84","author":"Stroman","year":"2015","journal-title":"Neuroimage"},{"key":"2021021220580857800_awaa347-B53","first-page":"1082","article-title":"The current state-of-the-art of spinal cord imaging: applications","author":"Stroman","year":"2015","journal-title":"Neuroimage"},{"key":"2021021220580857800_awaa347-B54","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/1352458514531087","article-title":"Magnetic resonance imaging in neuromyelitis optica","author":"Tackley","year":"2014","journal-title":"Mult Scler"},{"key":"2021021220580857800_awaa347-B55","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1212\/WNL.0000000000002366","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"86","author":"Tan","year":"2016","journal-title":"Neurology"},{"key":"2021021220580857800_awaa347-B56","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1212\/WNL.0000000000005853","article-title":"Spinal cord volume loss","volume":"91","author":"Tsagkas","year":"2018","journal-title":"Neurology"},{"key":"2021021220580857800_awaa347-B57","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pediatrneurol.2018.06.003","article-title":"Anti-myelin oligodendrocyte glycoprotein antibody associated with gray matter predominant transverse myelitis mimicking acute flaccid myelitis: a presentation of two cases","volume":"86","author":"Wang","year":"2018","journal-title":"Pediatr Neurol"},{"key":"2021021220580857800_awaa347-B58","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2164-11-9","article-title":"An integrated functional genomic study of acute phenobarbital exposure in the rat","volume":"11","author":"Waterman","year":"2010","journal-title":"BMC Genomics"},{"key":"2021021220580857800_awaa347-B59","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1212\/NXI.0000000000000089","article-title":"MOG cell-based assay detects non-MS patients with inflammatory neurologic disease","volume":"2","author":"Waters","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2021021220580857800_awaa347-B60","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ana.20770","article-title":"Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis","volume":"59","author":"Weinshenker","year":"2006","journal-title":"Ann Neurol"},{"key":"2021021220580857800_awaa347-B61","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/cen3.12107","article-title":"Evaluation of aquaporin-4 antibody assays","volume":"5","author":"Wingerchuk","year":"2014","journal-title":"Clin Exp Neuroimmunol"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/144\/1\/198\/36247702\/awaa347.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/144\/1\/198\/36247702\/awaa347.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T20:50:13Z","timestamp":1613163013000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/144\/1\/198\/5989776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,18]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,11,18]]},"published-print":{"date-parts":[[2021,2,12]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awaa347","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1,1]]},"published":{"date-parts":[[2020,11,18]]}}}